Treatment options for the management of pervasive developmental disorders

K Nash, KJ Carter - The International Journal of Psychiatry …, 2016 - journals.sagepub.com
Autism spectrum disorder (previously known as pervasive developmental disorders) is
characterized by social communication deficits, impaired functioning, and restrictive or …

Recent advances in the pharmacological management of behavioral disturbances associated with autism spectrum disorder in children and adolescents

M Lamy, EV Pedapati, KL Dominick, LK Wink… - Pediatric Drugs, 2020 - Springer
Autism spectrum disorder (ASD) is a heterogeneous neuropsychiatric condition affecting an
estimated one in 36 children. Youth with ASD may have severe behavioral disturbances …

Pharmacological treatment options for autism spectrum disorders in children and adolescents

TJ Leskovec, BM Rowles… - Harvard review of …, 2008 - journals.lww.com
Autism and other pervasive developmental disorders (PDDs) are frequently associated with
dysfunctional behaviors and are characterized by deficits in socialization, communication …

Pharmacotherapy of Autism and Related Disorders.

CA Erickson, DJ Posey, KA Stigler… - Psychiatric …, 2007 - search.ebscohost.com
The article discusses pharmacotherapy options in pervasive developmental disorders (PDD)
based upon the following target symptom clusters: inattention/hyperactivity, interfering …

Current state and future prospects of pharmacological interventions for autism

A Vahabzadeh, D Buxton, CJ McDougle… - …, 2013 - search.proquest.com
Autism spectrum disorder (ASD) is a group of heterogeneous developmental disorders
manifesting in early childhood. They are associated with a range of core and associated …

Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders

LK Wink, CA Erickson, CJ McDougle - Current Treatment Options in …, 2010 - Springer
Opinion statement Pervasive developmental disorders (PDDs), including autistic disorder
(autism), Asperger's disorder, and pervasive developmental disorder not otherwise specified …

Potential benefits and limits of psychopharmacological therapies in pervasive developmental disorders

M Molteni, M Nobile, D Cattaneo… - Current Clinical …, 2014 - ingentaconnect.com
The core symptoms of Autistic Spectrum Disorder (ASD) are impairment in reciprocal social
interaction, communication, narrow interests, and stereotyped behaviour. These are …

Pharmacologic treatment of autism and related disorders

CA Erickson, DJ Posey, KA Stigler… - Pediatric …, 2007 - journals.healio.com
Ei: 33EEEEEEEEE"| EEEEEEEEEE| n recent years increasingly rigorous pharmacotherapy
study has addressed interfering symptoms asso-ciated with autism and related pervasive …

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders

LK Wink, MH Plawecki, CA Erickson… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Autism spectrum disorders, or pervasive developmental disorders
(PDDs), are neurodevelopmental disorders defined by qualitative impairment in social …

Non-pharmacological treatments in autism spectrum disorders: an overview on early interventions for pre-schoolers

A Narzisi, C Costanza, B Umberto… - Current clinical …, 2014 - ingentaconnect.com
This paper evaluates the current literature on non-pharmacological early interventions
(behavior behavioral, developmental and educational approaches) for pre-schoolers (aged …